你即將離開本站

並前往https://www.kyowakirin.com/media_center/news_releases/2013/e20131031_02.html

Results of a Phase 2 Study of KHK4827 in Subjects with Psoriasis in ...

... today that KHK4827 (Generic name: brodalumab) achieved the primary efficacy endpoint in a phase 2 study to treat subjects with plaque psoriasis in Japan.

確定！ 回上一頁

查詢 「plaque psoriasis中文」的人也找了：

  1. scalp psoriasis中文
    2.
  2. 牛皮癬英文
    3.
  3. inverse psoriasis中文
    4.
  4. psoriatic arthritis中文
    5.
  5. pustular psoriasis中文
    6.
  6. psoriasis vulgaris中文
    7.
  7. 牛皮癬成因
    8.
  8. 乾癬英文
    9.